Correlation Between OncoSec Medical and Hillstream Biopharma
Can any of the company-specific risk be diversified away by investing in both OncoSec Medical and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoSec Medical and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoSec Medical and Hillstream Biopharma, you can compare the effects of market volatilities on OncoSec Medical and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoSec Medical with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoSec Medical and Hillstream Biopharma.
Diversification Opportunities for OncoSec Medical and Hillstream Biopharma
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between OncoSec and Hillstream is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding OncoSec Medical and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and OncoSec Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoSec Medical are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of OncoSec Medical i.e., OncoSec Medical and Hillstream Biopharma go up and down completely randomly.
Pair Corralation between OncoSec Medical and Hillstream Biopharma
If you would invest 39.00 in Hillstream Biopharma on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Hillstream Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
OncoSec Medical vs. Hillstream Biopharma
Performance |
| Timeline |
| OncoSec Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Hillstream Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
OncoSec Medical and Hillstream Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OncoSec Medical and Hillstream Biopharma
The main advantage of trading using opposite OncoSec Medical and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoSec Medical position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.| OncoSec Medical vs. ZyVersa Therapeutics | OncoSec Medical vs. Palisade Bio | OncoSec Medical vs. Unicycive Therapeutics | OncoSec Medical vs. Immix Biopharma |
| Hillstream Biopharma vs. Virax Biolabs Group | Hillstream Biopharma vs. Revelation Biosciences | Hillstream Biopharma vs. Kiora Pharmaceuticals | Hillstream Biopharma vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |